The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
Open accessAbstract
BACKGROUND: Plasmacytoid dendritic cells have been implicated in the pathogenesis of systemic sclerosis through mechanisms beyond the previously suggested production of type I interferon. METHODS: We isolated plasmacytoid dendritic cells from healthy persons and from patients with systemic sclerosis who had distinct clinical phenotypes. We then performed proteome-wide analysis and validated these observations in five large cohorts of patients with systemic sclerosis. Next, we compared the results with those in patients with systemic lupus erythematosus, ankylosing spondylitis, and hepatic fibrosis. We correlated plasma levels of CXCL4 protein with features of systemic sclerosis and studied the direct effects of CXCL4 in vitro and in vivo. RESULTS: Proteome-wide analysis and validation showed that CXCL4 is the predominant protein secreted by plasmacytoid dendritic cells in systemic sclerosis, both in circulation and in skin. The mean (±SD) level of CXCL4 in patients with systemic sclerosis was 25,624±2652 pg per milliliter, which was significantly higher than the level in controls (92.5±77.9 pg per milliliter) and than the level in patients with systemic lupus erythematosus (1346±1011 pg per milliliter), ankylosing spondylitis (1368±1162 pg per milliliter), or liver fibrosis (1668±1263 pg per milliliter). CXCL4 levels correlated with skin and lung fibrosis and with pulmonary arterial hypertension. Among chemokines, only CXCL4 predicted the risk and progression of systemic sclerosis. In vitro, CXCL4 down-regulated expression of transcription factor FLI1, induced markers of endothelial-cell activation, and potentiated responses of toll-like receptors. In vivo, CXCL4 induced the influx of inflammatory cells and skin transcriptome changes, as in systemic sclerosis. CONCLUSIONS: Levels of CXCL4 were elevated in patients with systemic sclerosis and correlated with the presence and progression of complications, such as lung fibrosis and pulmonary arterial hypertension. (Funded by the Dutch Arthritis Association and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Gottenberg, J.-E., Cagnard, N., Lucchesi, C., Letourneur, F., Mistou, S., Lazure, T., Jacques, S., Ba, N., Ittah, M., Lepajolec, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510837103 · Cited by 611
Rollins, B. J. (1997) · PubMed · Cited by 603
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Spanish Scleroderma Group, Radstake, T. R. D. J., Gorlova, O., Rueda, B., Martin, J.-E., Alizadeh, B. Z., Palomino-Morales, R., Coenen, M. J., Vonk, M. C., Voskuyl, A. E., et al. (2010) · Nature Genetics · doi:10.1038/ng.565 · Cited by 401
Self-citationYork, M. R., Nagai, T., Mangini, A. J., Lemaire, R., van Seventer, J. M., & Lafyatis, R. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22382 · Cited by 327
Self-citationvan der Pouw Kraan, T. C. T. M., Wijbrandts, C. A., van Baarsen, L. G. M., Voskuyl, A. E., Rustenburg, F., Baggen, J. M., Ibrahim, S. M., Fero, M., Dijkmans, B. A. C., Tak, P. P., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.063412 · Cited by 313
The innate immune system in SLE: type I interferons and dendritic cells
Rönnblom, L., & Pascual, V (2008) · Lupus · doi:10.1177/0961203308090020 · Cited by 312
van der Heijde, D. M. F. M., Bellamy, N., Călin, A., Dougados, M., Ma, K., & van der Linden, S. (1997) · PubMed · Cited by 240
KAHALEH, M. B., OSBORN, I., & LeROY, E. C. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-4-482 · Cited by 221
Eloranta, M.-L., Franck-Larsson, K., Lövgren, T., Kalamajski, S., Rönnblom, A., Rubin, K., Alm, G. V., & Rönnblom, L. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.121400 · Cited by 202
Connective tissue synthesis by scleroderma skin fibroblasts in cell culture
Leroy, E. C. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.135.6.1351 · Cited by 201
Rajkumar, R., Konishi, K., Richards, T. J., Ishizawar, D. C., Wiechert, A. C., Kaminski, N., & Ahmad, F. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00254.2009 · Cited by 196
Endothelial Fli1 Deficiency Impairs Vascular Homeostasis
Asano, Y., Stawski, L., Hant, F., Highland, K., Silver, R., Szalai, G., Watson, D. K., & Trojanowska, M. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090593 · Cited by 194
Self-citationDieudé, P., Guedj, M., Wipff, J., Avouac, J., Fajardy, I., Diot, E., Granel, B., Sibilia, J., Cabane, J., Mouthon, L., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24183 · Cited by 188
Radstake, T. R. D. J., van Bon, L., Broen, J., Wenink, M., Santegoets, K., Deng, Y., Hussaini, A., Simms, R., Cruikshank, W. W., & Lafyatis, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005981 · Cited by 185
Self-citationPitsilos, S., Hunt, J., Mohler, E., Prabhakar, A., Poncz, M., Dawicki, J., Khalapyan, T., L.Wolfe, M., Fairman, R., Mitchell, M., et al. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0069 · Cited by 182
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype
Rueda, B., Broen, J., Simeon, C., Hesselstrand, R., Diaz, B., Suarez, H., Ortego-Centeno, N., Riemekasten, G., Fonollosa, V., Vonk, M. C., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp119 · Cited by 178
Self-citationCXC chemokine ligand 4 (Cxcl4) is a platelet‐derived mediator of experimental liver fibrosis†
Zaldivar, M. M., Pauels, K., von Hundelshausen, P., Berres, M., Schmitz, P., Bornemann, J., Kowalska, M. A., Gassler, N., Streetz, K. L., Weiskirchen, R., et al. (2010) · Hepatology · doi:10.1002/hep.23435 · Cited by 171
A four‐gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis
Farina, G., Lafyatis, D., Lemaire, R., & Lafyatis, R. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27220 · Cited by 170
Self-citationKubo, M., Czuwara-Ladykowska, J., Moussa, O., Markiewicz, M., Smith, E., Silver, R. M., Jablonska, S., Blaszczyk, M., Watson, D. K., & Trojanowska, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63685-1 · Cited by 169
Self-citationThe Immunobiology of Systemic Sclerosis
Gu, Y. S., Kong, J., Cheema, G. S., Keen, C. L., Wick, G., & Gershwin, M. E. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2007.10.010 · Cited by 167
Kim, D., Peck, A., Santer, D., Patole, P., Schwartz, S. M., Molitor, J. A., Arnett, F. C., & Elkon, K. B. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23486 · Cited by 166
Liu, C. Y., Battaglia, M., Lee, S. H., Sun, Q., Aster, R. H., & Visentin, G. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2680 · Cited by 134
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production
Romagnani, P., Maggi, L., Mazzinghi, B., Cosmi, L., Lasagni, L., Liotta, F., Lazzeri, E., Angeli, R., Rotondi, M., Filì, L., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.035 · Cited by 117
CXCL10 ( ) and CCL2 ( ) chemokines in systemic sclerosis a longitudinal study
Antonelli, A., Ferri, C., Fallahi, P., Ferrari, S. M., Giuggioli, D., Colaci, M., Manfredi, A., Frascerra, S., Franzoni, F., Galetta, F., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem313 · Cited by 114
Gourh, P., Agarwal, S. K., Divecha, D., Assassi, S., Paz, G., Arora-Singh, R. K., Reveille, J. D., Shete, S. S., Mayes, M. D., Arnett, F. C., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24958 · Cited by 109
Self-citationHasegawa, M., Fujimoto, M., Matsushita, T., Hamaguchi, Y., Takehara, K., & Sato, S. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1610-4 · Cited by 91
Innate immunity and inflammation in systemic sclerosis
Lafyatis, R., & York, M. R. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32832fd69e · Cited by 79
Self-citationThe Metabolic Syndrome and Its Traits as Risk Factors for Subclinical Atherosclerosis
Holewijn, S., den Heijer, M., Swinkels, D. W., Stalenhoef, A. F. H., & Graaf, J. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0084 · Cited by 62
The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis
Aïdoudi, S., Bujakowska, K. M., Kieffer, N., & Bikfalvi, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002657 · Cited by 49
Farina, G. A., York, M. R., Collins, C., & Lafyatis, R. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132464 · Cited by 43
Self-citation
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
The multifaceted biology of plasmacytoid dendritic cells
Swiecki, M., & Colonna, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3865 · Cited by 1,131
Allanore, Y., Simms, R., Distler, O., Trojanowska, M., Pope, J., Denton, C. P., & Varga, J. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.2 · Cited by 876
Self-citationPlasmacytoid Dendritic Cells: Development, Regulation, and Function
Reizis, B. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.027 · Cited by 673
Metadata
- Authors
- van Bon, L., Affandi, A. J., Broen, J., Christmann, R. B., Marijnissen, R. J., Stawski, L., Farina, G. A., Stifano, G., Mathes, A. L., Cossu, M., York, M., Collins, C., Wenink, M., Huijbens, R., Hesselstrand, R., Saxne, T., DiMarzio, M., Wuttge, D., Agarwal, S. K., Reveille, J. D., Assassi, S., Mayes, M., Deng, Y., Drenth, J. P. H., de Graaf, J., den Heijer, M., Kallenberg, C. G. M., Bijl, M., Loof, A., van den Berg, W. B., Joosten, L. A. B., Smith, V., de Keyser, F., Scorza, R., Lunardi, C., van Riel, P. L. C. M., Vonk, M., van Heerde, W., Meller, S., Homey, B., Beretta, L., Roest, M., Trojanowska, M., Lafyatis, R., & Radstake, T. R. D. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-01-30
- Volume
- 370
- Issue
- 5
- Pages
- 433-443
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154576801
- Cited by
- 453
- References
- 36
- FWCI
- 21.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.